ArticleCureus2024

Assessing a Novel Thyroid-Stimulating Antibody Bioassay as a Predictor of Radioactive Iodine Therapy Efficacy in Graves' Disease.

Seigo Tachibana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.